BACE1 and Alzheimer disease: In conclusion, this preliminary study regarding aptamer identification using a SELEX strategy provides novel evidence that aptamers have the ability to inhibit BACE1 activity in an AD cell model and supports its potential in the development of a novel and specific BACE1 inhibitor.